Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Detoxification

In toxicology, Björklund Pharma offers advanced solutions designed to mitigate the effects of toxic substances and restore normal redox balance within the body. These products focus on potent thiol-based antioxidants and metal chelators, which effectively penetrate cell membranes to address toxicity at the cellular level.

Product Candidates

Diaminoethyl-dithiolhexane

Diaminoethyl-dithiolhexane (DAE-DTH), also known as 1,4-bis(2-aminoethyl)-2,5-dithiolhexane, is a chelating agent developed by Björklund Pharma with a specific affinity for mercury ions (Hg²⁺). Read More

BDTH2

BDTH2 (N,N′-bis-(2-mercaptoethyl) isophthalamide, NBMI, emeramide) is a thiol-redox antioxidant and metal chelator designed to penetrate cell membranes and cross the blood-brain barrier. BDTH2 is effective in scavenging hydroxyl free radicals and reducing the toxicity levels of these dangerous molecules, which can disrupt the normal redox status of cells. This compound is ideal for managing oxidative stress and heavy metal toxicity, offering a comprehensive approach to restoring cellular health. Read More

InBio LiverGuard

This is a natural liver support formula designed to enhance the body’s detoxification processes. It includes milk thistle extract, N-acetyl cysteine (NAC), and alpha-lipoic acid, which synergistically support liver function, promote glutathione production, and protect against oxidative stress. LiverGuard is a complementary product to DAE-DTH and BDTH2, supporting overall detoxification and liver health. Read More

InBio DetoxiShield

This detox supplement is formulated with natural ingredients known for their detoxifying properties, including chlorella, spirulina, cilantro, and activated charcoal. InBio DetoxiShield helps the body eliminate many environmental toxins, supporting overall health and well-being. DetoxiShield can be used as part of a regular detox regimen or in conjunction with specific chelation therapies. Read More

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS